Improving the Safety of Blood Glucose Monitoring

Klonoff DC . The food and drug administration is now preparing to establish tighter performance requirements for blood glucose monitors. J Diabetes Sci Technol. 2010;4 (3): 499–504.

May 2010 Clinical Laboratory News: Blood Glucose Meters. http://www.aacc.org/publications/cln/2010/may/Pages/CoverStory1May2010.aspx. Accessed October 9, 2011.

Thompson ND Perz JF . Eliminating the blood: Ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol. 2009;3 (2): 283–8.

Counard CA Perz JF Linchangco PC Christiansen D Ganova-Raeva L Xia G Jones S Vernon MO . Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc. 2010;58 (2): 306–11.

Thompson N Schaefer T . “Never Events”: Hepatitis B Outbreaks and Patient Notifications Resulting from Unsafe Practices during Assisted Monitoring of Blood Glucose, 2009–2010. J Diabetes Sci Technol. 2011;5 (6): 1396–1402.

Schaefer MK Jhung M Dahl M Schillie S Simpson C Llata E Link-Gelles R Sinkowitz-Cochran R Patel P Bolyard E Sehulster L Srinivasan A Perz JF . Infection control assessment of ambulatory surgical centers. JAMA. 2010;303 (22): 2273–9.

Thompson ND Barry V Alelis K Cui D Perz JF . Evaluation of the potential for bloodborne pathogen transmission associated with diabetes care practices in nursing homes and assisted living facilities, Pinellas County. J Am Geriatr Soc. 2010;58 (5): 914–8.

Klonoff DC Perz JF . Assisted monitoring of blood glucose: Special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol. 2010;4 (5): 1027–31.

Fingerstick Devices to Obtain Blood Specimens: Initial Communication — Risk of Transmitting Bloodborne Pathogens. Reusable fingerstick (blood lancing) devices and point of care (POC) blood testing devices (e.g., blood glucose meters, PT/INR anticoagulation meters, cholesterol testing devices). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224135.htm. Accessed October 9, 2011.

Infection Prevention during Blood Glucose Monitoring and Insulin Administration. http://www.cdc.gov/injectionsafety/blood-glucose-monitoring.html. Accessed October 9, 2011.

Letter to Manufacturers of Blood Glucose Monitoring Systems Listed with the FDA. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm227935.htm. Accessed October 9, 2011.

Pfützner A Musholt PB Malmgren-Hansen B Nilsson NH Forst T . Analysis of the environmental impact of insulin infusion sets based on loss of resources with waste. J Diabetes Sci Technol. 2011;5 (4): 843–7.

Krisiunas E . Waste disposal in the 21st century and diabetes technology: A little coffee (cup) or beer (can) with that insulin infusion (set). J Diabetes Sci Technol. 2011;5 (4): 851–2.

Self-Monitoring of Blood Glucose Among Adults with Diabetes— United States, 1997–2006. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5643a3.htm#tab1. Accessed October 9, 2011.

National Diabetes Fact Sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed October 9, 2011.

Gold K . Analysis: The impact of needle, syringe, and lancet disposal on the community. J Diabetes Sci Technol. 2011;5 (4): 848–50.

1BD eco Finity™ LifeCycle Solution. Turning a waste stream into a resource stream. http://www.bd.com/ecoFinity/flash/slide-show-14260.htm. Accessed October 8, 2011.

Jacoby JM . An analysis of alternate site tests to improve patient compliance with self-monitoring of blood glucose. J Diabetes Sci Technol. 2010;4 (4): 911–2.

Ellison JM Stegmann JM Colner SL Michael RH Sharma MK Ervin KR Horwitz DL . Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care. 2002;25 (6): 961–4.

Kempe KC Budd D Stern M Ellison JM Saari LA Adiletto CA Olin B Price DA Horwitz DL . Palm glucose readings compared with fingertip readings under steady and dynamic glycemic conditions, using the OneTouch Ultra Blood Glucose Monitoring System. Diabetes Technol Ther. 2005;7 (6): 916–26.

Heinemann L Boecker D . Lancing: Quo vadis? J Diabetes Sci Technol. 2011;5 (4): 966–81.

Kocher S Tshiananga JK Koubek R . Comparison of lancing devices for self-monitoring of blood glucose regarding lancing pain. J Diabetes Sci Technol. 2009;3 (5): 1136–43.

Lekarcyk J Ghiloni S . Analysis of the comparison of lancing devices for self-monitoring of blood glucose regarding lancing pain. J Diabetes Sci Technol. 2009;3 (5): 1144–5.

Bina DM Anderson RL Johnson ML Bergenstal RM Kendall DM . Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care. 2003;26 (4): 981–5.

ISO 15197. http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=54976. Accessed October 9, 2011.

Clarke WL Cox D Gonder-Frederick LA Carter W Pohl SL . Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987;10 (5): 622–8.

Parkes JL Slatin SL Pardo S Ginsberg BH . A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23 (8): 1143–8.

Krouwer JS Cembrowski GS . Towards more complete specifications for acceptable analytical performance — A plea for error grid analysis. Clin Chem Lab Med. 2011;49: 1127–30.

Carraro P Plebani M . Post-analytical errors with portable glucose meters in the hospital setting. Clin Chim Acta. 2009;404 (1): 65–7.

Medical Device Safety. http://www.fda.gov/MedicalDevices/Safety/default.htm. Accessed October 9, 2011.